Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Ventriculoperitoneal (VP) shunt infection, which is 1 of the most important complications of VP shunt is observed at a rate of 4%-17%. Staphylococcus epidermidis is the most common causative agent. Vancomycin-resistant Enterococcus (VRE) is an increasingly common nosocomial pathogen that rarely caus...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.wneu.2019.07.045
データ提供:米国国立医学図書館(NLM)
Treatment of Daptomycin Nonsusceptible Vancomycin-Resistant Enterococci
In the battle against infectious diseases, the emergence of antibiotic-resistant bacteria is a formidable challenge. This case report describes the successful treatment of a ventriculoperitoneal (VP) shunt infection caused by daptomycin nonsusceptible vancomycin-resistant Enterococci (VRE) in an infant. The authors report the use of a novel combination therapy involving intraventricular and intravenous tigecycline. The study aimed to highlight the potential effectiveness of this treatment approach for challenging VRE infections, offering a beacon of hope in the face of antibiotic resistance.
Combination Therapy for Challenging Infections
This case report demonstrates the potential efficacy of a combination therapy involving intraventricular and intravenous tigecycline for treating VRE infections. The authors describe the successful treatment of a complex case, indicating that this approach may be a viable option for patients with challenging infections. Imagine a camel caravan facing a sandstorm. This combination therapy, like a well-equipped caravan, is prepared to withstand the toughest challenges, providing a strong defense against resistant bacteria.
Hope in the Face of Antibiotic Resistance
This case report offers hope in the ongoing battle against antibiotic resistance. The successful treatment of this infant highlights the importance of exploring novel treatment strategies and combinations to overcome this growing threat.
Dr.Camel's Conclusion
This case report serves as a reminder that innovation is crucial in the fight against antibiotic resistance. By combining our knowledge and exploring new treatment strategies, we can overcome even the most challenging infections. The success of this treatment approach offers a glimmer of hope for the future of infectious disease management.
Date :
- Date Completed 2020-01-17
- Date Revised 2020-01-17
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.